Bicetre Hospital

Le Kremlin-Bicêtre 94275

1 studies enrolling now · 2 studies all time

What they study most

Proteinuric Kidney Disease, X-linked Hypophosphatemia

Studies at this site

• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH) — Completed